Symbol="OVID"
AssetType="Common Stock"
Name="Ovid Therapeutics Inc"
Description="Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York."
CIK="1636651"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1460 BROADWAY, SUITE 15044, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="261987000"
EBITDA="-52518532"
PERatio="None"
PEGRatio="0"
BookValue="1.568"
DividendPerShare="0"
DividendYield="0"
EPS="-0.71"
RevenuePerShareTTM="0.003"
ProfitMargin="0"
OperatingMarginTTM="-267.66"
ReturnOnAssetsTTM="-0.212"
ReturnOnEquityTTM="-0.375"
RevenueTTM="198540"
GrossProfitTTM="1502700"
DilutedEPSTTM="-0.71"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.954"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="1.792"
PriceToSalesRatioTTM="87.09"
PriceToBookRatio="0.903"
EVToRevenue="4.56"
EVToEBITDA="-0.0966"
Beta="1.079"
num_52WeekHigh="3.98"
num_52WeekLow="1.405"
num_50DayMovingAverage="3.507"
num_200DayMovingAverage="2.718"
SharesOutstanding="70521000"
DividendDate="None"
ExDividendDate="None"
symbol="OVID"
open="3.76"
high="3.84"
low="3.60"
price="3.80"
volume="373568.00"
latest_trading_day="2023-08-17"
previous_close="3.78"
change="0.02"
change_percent="0.5291%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="18"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="82"
Volume_recent_avg="238400"
Change_recent_avg="0.02"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="0.56"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="82"
Aroon_momentum_negative="18"
image_negative_thumbnail_id_1="134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_negative_thumbnail_id_2="1106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="989"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
